Quiz: Emerging Therapies in DED

<section data-block="SingleChoice"><h3>Which of the following therapies is specifically designed to stimulate endogenous tear production through neurostimulation?</h3><ul><li>Perfluorohexyloctane</li><li>Lifitegrast</li><li>Nasal varenicline spray</li><li>Autologous serum eye drops</li></ul></section><section data-block="SingleChoice"><h3>What is the primary mechanism of action of perfluorohexyloctane in the treatment of dry eye disease?</h3><ul><li>Reduces ocular surface inflammation</li><li>Stimulates meibomian gland secretion</li><li>Increases aqueous tear production</li><li>Reduces excessive tear evaporation</li></ul></section><section data-block="SingleChoice"><h3>Which of the following diagnostic tools helps identify ocular surface inflammation by detecting a specific biomarker?</h3><ul><li>Tear osmolarity testing</li><li>Meibography</li><li>MMP-9 assay</li><li>Thermal pulsation imaging</li></ul></section>

Quiz: Emerging Therapies in DED

Related Content

Quiz: Topical Insulin for Persistent Corneal Epithelial Defects

Quiz: Neurotrophic Keratitis Management

Myopia management strategies: Test your knowledge

Family Ties in Glaucoma: A Screening Strategy Quiz

Quiz: Diagnosing and Treating AMD

Quiz: Medications and Systemic Conditions that Influence Dry Eye Disease